from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1007c/metS

LFCtreatmentdescriptionclass of inhibitor

-0.524

Amikacinug/mL Amikacintranslation

-1.674

Cap5-10ug/mL Capreomycintranslation

-2.003

Rox10-50 ug/mL Roxithromycintranslation

-0.089

SM2-5 ug/mL Streptomycintranslation

-2.157

Tet5-10 ug/mL Tetracyclinetranslation

1.219

Rif0.2-5ug/mL Rifampicintranscription

-0.038

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.242

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.142

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.022

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.258

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.433

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.371

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.547

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.146

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.035

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.472

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.399

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.152

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.156

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.339

KCN5-20 ug/mL Potassium cyaniderespiration

0.765

NaN30.2-2 mM Sodium aziderespiration

-0.393

Nigericin50 uM Nigericinrespiration

0.119

TRC10-150 ug/mL Triclosanrespiration

-0.200

TRZ10-25 ug/mL Thioridazinerespiration

-1.488

Valinomycin0.5-10 uM Valinomycinrespiration

0.019

ZnSO42 mM ZnSO4respiration

-0.669

menadione6-10 ug/mL Menadionerespiration

0.426

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.187

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.088

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.177

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.189

NRP_1Non-replicating persistence stage 1dosRassociated

-0.196

Amp0.2mg/mL AmpicillincellWall

0.061

Cephalexin20-100 ug/mL CephalexincellWall

-0.196

Cerulenin0.32-5 ug/mL CerulenincellWall

1.089

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.520

EMB10-20 ug/mL EthambutolcellWall

0.416

Eta12-40 ug/mL EthionamidecellWall

0.745

INH0.2-0.4 ug/mL IsoniazidcellWall

0.462

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.103

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.784

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.179

BZA0.12 mg/mL BenzamidearomaticAmides

0.235

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.230

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.388

H2O24 mM hydrogen peroxideDNAdamaging

0.399

Levo10 ug/mL LevofloxacinDNAdamaging

-0.419

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.055

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.462

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.012

UVUV-irradiationDNAdamaging

-0.494

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.270

Antimycin12.5-50 ug/mL Antimycin A?

-0.298

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.114

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.060

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.591

PA8240.2-2 ug/mL PA-824?

1.202

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.658

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.392

Verapamil50 uM Verapamil?

-0.355

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.597

methoxatin10-20 ug/mL Methoxatin?